Citations (79)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Susan S. Schiffman, Elizabeth H. Scholl, Terrence S. Furey & H. Troy Nagle. (2023) Toxicological and pharmacokinetic properties of sucralose-6-acetate and its parent sucralose: in vitro screening assays. Journal of Toxicology and Environmental Health, Part B 26:6, pages 307-341.
Read now
Read now
Susanne B Haga. (2020) Individualizing Pharmacogenomic Test Results in the Context of the Microbiome. Personalized Medicine 17:6, pages 459-468.
Read now
Read now
S. Cyrus Khojasteh, Grover P. Miller, Kaushik Mitra & Ivonne M. C. M. Rietjens. (2018) Biotransformation and bioactivation reactions – 2017 literature highlights. Drug Metabolism Reviews 50:3, pages 221-255.
Read now
Read now
Alexander J Prokopienko & Thomas D Nolin. (2018) Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease. Expert Review of Clinical Pharmacology 11:1, pages 71-82.
Read now
Read now
Barbara E. Ostrov & Daniel Amsterdam. (2017) Immunomodulatory interplay of the microbiome and therapy of rheumatic diseases. Immunological Investigations 46:8, pages 769-792.
Read now
Read now
Articles from other publishers (74)
Jakub Mrázek, Lucie Mrázková, Chahrazed Mekadim, Taťána Jarošíková, Imtissal Krayem, Yahya Sohrabi, Peter Demant & Marie Lipoldová. (2024) Effects of Leishmania major infection on the gut microbiome of resistant and susceptible mice. Applied Microbiology and Biotechnology 108:1.
Crossref
Crossref
Moataz E. MohamedAbdelrahman SaqrChristopher StaleyGuillaume OnyeaghalaLevi TeigenCasey R. DorrRory P. RemmelWeihua GuanWilliam S. OettingArthur J. MatasAjay K. IsraniPamala A. Jacobson. (2024) Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation. Transplantation.
Crossref
Crossref
Xin Y. Chu & Paul C.L. Ho. 2023. Oral Bioavailability and Drug Delivery. Oral Bioavailability and Drug Delivery
483
500
.
Rong Zhou, Haijun Yang, Peng Zhu, Yujie Liu, Yanjuan Zhang, Wei Zhang, Honghao Zhou, Xiong Li & Qing Li. (2023) Effect of Gut Microbiota on the Pharmacokinetics of Nifedipine in Spontaneously Hypertensive Rats. Pharmaceutics 15:8, pages 2085.
Crossref
Crossref
Alexandra L. Degraeve, Vincent Haufroid, Axelle Loriot, Laurent Gatto, Vanessa Andries, Lars Vereecke, Laure Elens & Laure B. Bindels. (2023) Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1. Microbiome 11:1.
Crossref
Crossref
Haijun Yang, Yanjuan Zhang, Rong Zhou, Tianyuan Wu, Peng Zhu, Yujie Liu, Jian Zhou, Yalan Xiong, Yanling Xiong, Honghao Zhou, Wei Zhang, Yan Shu, Xiong Li & Qing Li. (2023) Antibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe Drugs. Drug Metabolism and Disposition 51:4, pages 509-520.
Crossref
Crossref
Anpeng Zhao, Wenbin Li & Rong Wang. (2023) The Influences and Mechanisms of High-altitude Hypoxia Exposure on Drug Metabolism. Current Drug Metabolism 24:3, pages 152-161.
Crossref
Crossref
Tatsuya Yagi, Buster Mannheimer, Johan Reutfors, Johan Ursing, Diego Hernan Giunta, Helle Kieler & Marie Linder. (2022) Bleeding events among patients concomitantly treated with direct oral anticoagulants and macrolide or fluoroquinolone antibiotics. British Journal of Clinical Pharmacology 89:2, pages 887-897.
Crossref
Crossref
Masao Togao, Takashi Kurakawa, Shinnosuke Tajima, Gaku Wagai, Yuki Ohta-Takada, Jun Otsuka, Akinobu Kurita & Koji Kawakami. (2023) Human gut microbiota influences drug-metabolizing enzyme hepatic Cyp3a: A human flora-associated mice study. The Journal of Toxicological Sciences 48:6, pages 333-343.
Crossref
Crossref
Sik Yu So, Qinglong Wu & Tor Savidge. 2023. Present Knowledge in Food Safety. Present Knowledge in Food Safety
812
828
.
Aneela Gulnaz, Ji-Eun Chang, Han-Joo Maeng, Kwang-Hee Shin, Kyeong-Ryoon Lee & Yoon-Jee Chae. (2022) A mechanism-based understanding of altered drug pharmacokinetics by gut microbiota. Journal of Pharmaceutical Investigation 53:1, pages 73-92.
Crossref
Crossref
Jun KyoungRohit R. AtluriTao Yang. (2022) Resistance to Antihypertensive Drugs: Is Gut Microbiota the Missing Link?. Hypertension 79:10, pages 2138-2147.
Crossref
Crossref
Lenka Jourova, Eva Anzenbacherova, Zdenek Dostal, Pavel Anzenbacher, Philippe Briolotti, Emilie Rigal, Martine Daujat-Chavanieu & Sabine Gerbal-Chaloin. (2022) Butyrate, a typical product of gut microbiome, affects function of the AhR gene, being a possible agent of crosstalk between gut microbiome, and hepatic drug metabolism. The Journal of Nutritional Biochemistry 107, pages 109042.
Crossref
Crossref
Noora Sjöstedt, Jeffry Adiwidjaja, William A. Murphy & Kim L.R. Brouwer. 2022. Drug Transporters. Drug Transporters
257
282
.
Moumita Dutta, Joe Jongpyo Lim & Julia Yue Cui. (2022) Pregnane X Receptor and the Gut-Liver Axis: A Recent Update. Drug Metabolism and Disposition 50:4, pages 478-491.
Crossref
Crossref
Stephen J. Keely, Andreacarola Urso, Alexandr V. Ilyaskin, Christoph Korbmacher, Nigel W. Bunnett, Daniel P. Poole & Simona E. Carbone. (2022) Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels. American Journal of Physiology-Gastrointestinal and Liver Physiology 322:2, pages G201-G222.
Crossref
Crossref
Eikan Mishima & Takaaki Abe. (2021) Role of the microbiota in hypertension and antihypertensive drug metabolism. Hypertension Research 45:2, pages 246-253.
Crossref
Crossref
Mallory Little, Moumita Dutta, Hao Li, Adam Matson, Xiaojian Shi, Gabby Mascarinas, Bruk Molla, Kris Weigel, Haiwei Gu, Sridhar Mani & Julia Yue Cui. (2022) Understanding the physiological functions of the host xenobiotic-sensing nuclear receptors PXR and CAR on the gut microbiome using genetically modified mice. Acta Pharmaceutica Sinica B 12:2, pages 801-820.
Crossref
Crossref
Xue Bai, Guiqin Liu, Jianxin Yang, Junbo Zhu & Xiangyang Li. (2022) Gut Microbiota as the Potential Mechanism to Mediate Drug Metabolism Under
High-altitude Hypoxia. Current Drug Metabolism 23:1, pages 8-20.
Crossref
Crossref
Yusha Luo & Tingting Zhou. (2021) Connecting the dots: Targeting the microbiome in drug toxicity. Medicinal Research Reviews 42:1, pages 83-111.
Crossref
Crossref
Shenhai Gong, Yinglin Feng, Yunong Zeng, Huanrui Zhang, Meiping Pan, Fangjie He, Rong Wu, Jingrui Chen, Jiuling Lu, Siyou Zhang, Songhua Yuan & Xia Chen. (2021) Gut microbiota accelerates cisplatin-induced acute liver injury associated with robust inflammation and oxidative stress in mice. Journal of Translational Medicine 19:1.
Crossref
Crossref
Zidong Donna Fu, Felcy Pavithra Selwyn, Julia Yue Cui & Curtis D. Klaassen. (2021) RNA-Seq unveiled section-specific host response to lack of gut microbiota in mouse intestine. Toxicology and Applied Pharmacology 433, pages 115775.
Crossref
Crossref
Masao Togao, Shinnosuke Tajima, Takashi Kurakawa, Gaku Wagai, Jun Otsuka, Shoichi Kado & Koji Kawakami. (2021) Normal variation of the gut microbiota affects hepatic cytochrome P450 activity in mice. Pharmacology Research & Perspectives 9:6.
Crossref
Crossref
Yedidya Saiman, Ting‐Chin David Shen, Peder J. Lund, Victoria M. Gershuni, Cholsoon Jang, Shivali Patel, Sunhee Jung, Emma E. Furth, Elliot S. Friedman, Lillian Chau, Benjamin A. Garcia & Gary D. Wu. (2021) Global Microbiota‐Dependent Histone Acetylation Patterns Are Irreversible and Independent of Short Chain Fatty Acids. Hepatology 74:6, pages 3427-3440.
Crossref
Crossref
Lisa Lemoine, Dilan Bayrambey, Alexander Roloff, Christoph Hutzler, Andreas Luch & Tewes Tralau. (2021)
Commensal-Related Changes in the Epidermal Barrier Function Lead to Alterations in the Benzo[
a
]Pyrene Metabolite Profile and Its Distribution in 3D Skin
. mBio 12:5.
Crossref
Crossref
Shirley M. Tsunoda, Christopher Gonzales, Alan K. Jarmusch, Jeremiah D. Momper & Joseph D. Ma. (2021) Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability. Clinical Pharmacokinetics 60:8, pages 971-984.
Crossref
Crossref
Paulina Średnicka, Edyta Juszczuk-Kubiak, Michał Wójcicki, Monika Akimowicz & Marek Ł. Roszko. (2021) Probiotics as a biological detoxification tool of food chemical contamination: A review. Food and Chemical Toxicology 153, pages 112306.
Crossref
Crossref
Takeshi Masuda, Ayano Mori, Shingo Ito & Sumio Ohtsuki. (2021) Quantitative and targeted proteomics-based identification and validation of drug efficacy biomarkers. Drug Metabolism and Pharmacokinetics 36, pages 100361.
Crossref
Crossref
Albert P. Li, Ming‐Chih D. Ho, Novera Alam, Walter Mitchell, Susan Wong, Zhengyin Yan, Jane R. Kenny & Cornelis E. C. A. Hop. (2020) Inter‐individual and inter‐regional variations in enteric drug metabolizing enzyme activities: Results with cryopreserved human intestinal mucosal epithelia (CHIM) from the small intestines of 14 donors. Pharmacology Research & Perspectives 8:5.
Crossref
Crossref
Eikan Mishima, Mariko Ichijo, Takeshi Kawabe, Koichi Kikuchi, Yukako Akiyama, Takafumi Toyohara, Takehiro Suzuki, Chitose Suzuki, Atsuko Asao, Naoto Ishii, Shinji Fukuda & Takaaki Abe. (2020) Germ-Free Conditions Modulate Host Purine Metabolism, Exacerbating Adenine-Induced Kidney Damage. Toxins 12:9, pages 547.
Crossref
Crossref
Jacinta Walsh, Cassandra E Gheorghe, Joshua M Lyte, Marcel van de Wouw, Marcus Boehme, Timothy G Dinan, John F Cryan, Brendan T Griffin, Gerard Clarke & Niall P Hyland. (2020) Gut microbiome-mediated modulation of hepatic cytochrome P450 and P-glycoprotein: impact of butyrate and fructo-oligosaccharide-inulin. Journal of Pharmacy and Pharmacology 72:8, pages 1072-1081.
Crossref
Crossref
Yuqi Wu, Yufei Zheng, Yanan Chen, Shuai Wang, Yanping Chen, Fuliang Hu & Huoqing Zheng. (2020)
Honey bee (
Apis mellifera
) gut microbiota promotes host endogenous detoxification capability via regulation of P450 gene expression in the digestive tract
. Microbial Biotechnology 13:4, pages 1201-1212.
Crossref
Crossref
Stephanie A. Flowers, Shubha Bhat & James C. Lee. (2020) Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40:7, pages 704-712.
Crossref
Crossref
Masao Togao, Koji Kawakami, Jun Otsuka, Gaku Wagai, Yuki Ohta‐Takada & Shoichi Kado. (2020) Effects of gut microbiota on in vivo metabolism and tissue accumulation of cytochrome P450 3A metabolized drug: Midazolam. Biopharmaceutics & Drug Disposition 41:7, pages 275-282.
Crossref
Crossref
Samantha M. Ervin, Siddharth Venkat Ramanan & Aadra P. Bhatt. (2020) Relationship Between the Gut Microbiome and Systemic Chemotherapy. Digestive Diseases and Sciences 65:3, pages 874-884.
Crossref
Crossref
Meng-Wei Niu & Peng Chen. (2020) Gut microbiota and drug-induced liver injury: an update. Chinese Medical Journal 133:4, pages 494-495.
Crossref
Crossref
Stephanie L. Collins & Andrew D. Patterson. (2020) The gut microbiome: an orchestrator of xenobiotic metabolism. Acta Pharmaceutica Sinica B 10:1, pages 19-32.
Crossref
Crossref
Joseph L. Dempsey & Julia Yue Cui. (2019) Microbiome Is a Functional Modifier of P450 Drug Metabolism. Current Pharmacology Reports 5:6, pages 481-490.
Crossref
Crossref
Jun‐jin Liu, Yao Cheng, Yun‐yun Shao, Zhuang‐peng Chang, Yi‐ting Guo, Xiao‐juan Feng, Ding Xu, Jing‐ping Zhang, Yan Song & Rui‐gang Hou. (2019) Comparative pharmacokinetics and metabolites study of seven major bioactive components of Shaoyao‐Gancao decoction in normal and polycystic ovary syndrome rats by ultra high pressure liquid chromatography with tandem mass spectrometry. Journal of Separation Science 42:15, pages 2534-2549.
Crossref
Crossref
Jie Tang, Jing Xu, Yue‐Li Zhang, Rong Liu, Mou‐Ze Liu, Yong‐Fang Hu, Ming‐Jie Shao, Li‐Jun Zhu, Shan Cao, Hua‐Wen Xin, Gui‐Wen Feng, Wen‐Jun Shang, Xiang‐Guang Meng, Li‐Rong Zhang, Ying‐Zi Ming, Wei Zhang & Gan Zhou. (2019) Incorporation of Gene‐Environment Interaction Terms Improved the Predictive Accuracy of Tacrolimus Stable Dose Algorithms in Chinese Adult Renal Transplant Recipients. The Journal of Clinical Pharmacology 59:6, pages 890-899.
Crossref
Crossref
Gerard Clarke, Kiran V. Sandhu, Brendan T. Griffin, Timothy G. Dinan, John F. Cryan & Niall P. Hyland. (2019) Gut Reactions: Breaking Down Xenobiotic–Microbiome Interactions. Pharmacological Reviews 71:2, pages 198-224.
Crossref
Crossref
Joseph L Dempsey, Dongfang Wang, Gunseli Siginir, Qiang Fei, Daniel Raftery, Haiwei Gu & Julia Yue Cui. (2019) Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis. Toxicological Sciences 168:1, pages 40-60.
Crossref
Crossref
Yaru Xue, Chenhui Ma, Imad Hanna & Guoyu Pan. 2019. Drug Transporters in Drug Disposition, Effects and Toxicity. Drug Transporters in Drug Disposition, Effects and Toxicity
361
405
.
Joseph Dempsey, Angela Zhang & Julia Yue Cui. (2018) Coordinate regulation of long non-coding RNAs and protein-coding genes in germ-free mice. BMC Genomics 19:1.
Crossref
Crossref
Edward T. Morgan, Joseph L. Dempsey, Sylvie M. Mimche, Tracey J. Lamb, Supriya Kulkarni, Julia Yue Cui, Hyunyoung Jeong & Angela L. Slitt. (2018) Physiological Regulation of Drug Metabolism and Transport: Pregnancy, Microbiome, Inflammation, Infection, and Fasting. Drug Metabolism and Disposition 46:5, pages 503-513.
Crossref
Crossref
Zidong Donna Fu, Felcy P. Selwyn, Julia Yue Cui & Curtis D. Klaassen. (2017) RNA-Seq Profiling of Intestinal Expression of Xenobiotic Processing Genes in Germ-Free Mice. Drug Metabolism and Disposition 45:12, pages 1225-1238.
Crossref
Crossref
Cindy Yanfei Li, Soowan Lee, Sara Cade, Li-Jung Kuo, Irvin R. Schultz, Deepak K. Bhatt, Bhagwat Prasad, Theo K. Bammler & Julia Yue Cui. (2017) Novel Interactions between Gut Microbiome and Host Drug-Processing Genes Modify the Hepatic Metabolism of the Environmental Chemicals Polybrominated Diphenyl Ethers. Drug Metabolism and Disposition 45:11, pages 1197-1214.
Crossref
Crossref
L. Jourová, P. Anzenbacher, B. Lišková, Z. Matušková, P. Hermanová, T. Hudcovic, H. Kozáková, L. Hrnčířová & E. Anzenbacherová. (2017) Colonization by non-pathogenic bacteria alters mRNA expression of cytochromes P450 in originally germ-free mice. Folia Microbiologica 62:6, pages 463-469.
Crossref
Crossref
Kentaro Nobutani, Jun Miyoshi, Mark W. Musch, Mitsue Nishiyama, Junko Watanabe, Atsushi Kaneko, Masahiro Yamamoto, Masaru Yoshida, Toru Kono, Hyunyoung Jeong & Eugene B. Chang. (2017) Daikenchuto (TU‐100) alters murine hepatic and intestinal drug metabolizing enzymes in an in vivo dietary model: effects of gender and withdrawal. Pharmacology Research & Perspectives 5:5.
Crossref
Crossref
Tomokazu Hata, Yasunari Asano, Kazufumi Yoshihara, Tae Kimura-Todani, Noriyuki Miyata, Xue-Ting Zhang, Shu Takakura, Yuji Aiba, Yasuhiro Koga & Nobuyuki Sudo. (2017) Regulation of gut luminal serotonin by commensal microbiota in mice. PLOS ONE 12:7, pages e0180745.
Crossref
Crossref
Pierre-André Billat, Emilie Roger, Sébastien Faure & Frédéric Lagarce. (2017) Models for drug absorption from the small intestine: where are we and where are we going?. Drug Discovery Today 22:5, pages 761-775.
Crossref
Crossref
Nobutomo Ikarashi, Sosuke Ogawa, Ryuta Hirobe, Risako Kon, Yoshiki Kusunoki, Marin Yamashita, Nanaho Mizukami, Miho Kaneko, Nobuyuki Wakui, Yoshiaki Machida & Kiyoshi Sugiyama. (2017) Epigallocatechin gallate induces a hepatospecific decrease in the CYP3A expression level by altering intestinal flora. European Journal of Pharmaceutical Sciences 100, pages 211-218.
Crossref
Crossref
Ian D. Wilson & Jeremy K. Nicholson. (2017) Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Translational Research 179, pages 204-222.
Crossref
Crossref
Renuka R. Nayak & Peter J. Turnbaugh. (2016) Mirror, mirror on the wall: which microbiomes will help heal them all?. BMC Medicine 14:1.
Crossref
Crossref
Takuya Kuno, Mio Hirayama-Kurogi, Shingo Ito & Sumio Ohtsuki. (2016) Effect of Intestinal Flora on Protein Expression of Drug-Metabolizing Enzymes and Transporters in the Liver and Kidney of Germ-Free and Antibiotics-Treated Mice. Molecular Pharmaceutics 13:8, pages 2691-2701.
Crossref
Crossref
F. P. Selwyn, S. L. Cheng, C. D. Klaassen & J. Y. Cui. (2015) Regulation of Hepatic Drug-Metabolizing Enzymes in Germ-Free Mice by Conventionalization and Probiotics. Drug Metabolism and Disposition 44:2, pages 262-274.
Crossref
Crossref
Hollie I. Swanson. (2015) Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?. Drug Metabolism and Disposition 43:10, pages 1499-1504.
Crossref
Crossref
Curtis D. Klaassen & Julia Yue Cui. (2015) Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids. Drug Metabolism and Disposition 43:10, pages 1505-1521.
Crossref
Crossref
Lian Yee Yip & Eric Chun Yong Chan. (2015) Investigation of Host–Gut Microbiota Modulation of Therapeutic Outcome. Drug Metabolism and Disposition 43:10, pages 1619-1631.
Crossref
Crossref
Felcy Pavithra Selwyn, Julia Yue Cui & Curtis D. Klaassen. (2015) RNA-Seq Quantification of Hepatic Drug Processing Genes in Germ-Free Mice. Drug Metabolism and Disposition 43:10, pages 1572-1580.
Crossref
Crossref
Felcy Pavithra Selwyn, Sunny Lihua Cheng, Theo K. Bammler, Bhagwat Prasad, Marc Vrana, Curtis Klaassen & Julia Yue Cui. (2015) Developmental Regulation of Drug-Processing Genes in Livers of Germ-Free Mice. Toxicological Sciences 147:1, pages 84-103.
Crossref
Crossref
Lucia A Possamai, Mark JW McPhail, Wafa Khamri, Bishan Wu, Danilo Concas, Mark Harrison, Roger Williams, Roger D Cox, I Jane Cox, Quentin M Anstee & Mark R Thursz. (2014) The role of intestinal microbiota in murine models of acetaminophen‐induced hepatotoxicity. Liver International 35:3, pages 764-773.
Crossref
Crossref
Rachel N. Carmody & Peter J. Turnbaugh. (2014) Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. Journal of Clinical Investigation 124:10, pages 4173-4181.
Crossref
Crossref
Yoshiki Kusunoki, Nobutomo Ikarashi, Yoshitaka Hayakawa, Makoto Ishii, Risako Kon, Wataru Ochiai, Yoshiaki Machida & Kiyoshi Sugiyama. (2014) Hepatic early inflammation induces downregulation of hepatic cytochrome P450 expression and metabolic activity in the dextran sulfate sodium-induced murine colitis. European Journal of Pharmaceutical Sciences 54, pages 17-27.
Crossref
Crossref
Makoto Ishii, Takahiro Toda, Nobutomo Ikarashi, Yoshiki Kusunoki, Risako Kon, Wataru Ochiai, Yoshiaki Machida & Kiyoshi Sugiyama. (2014) Gastrectomy Increases the Expression of Hepatic Cytochrome P450 3A by Increasing Lithocholic Acid-Producing Enteric Bacteria in Mice. Biological and Pharmaceutical Bulletin 37:2, pages 298-305.
Crossref
Crossref
Makoto Ishii, Takahiro Toda, Nobutomo Ikarashi, Yoshiki Kusunoki, Risako Kon, Wataru Ochiai, Yoshiaki Machida & Kiyoshi Sugiyama. (2014) Total gastrectomy may result in reduced drug effectiveness due to an increase in the expression of the drug-metabolizing enzyme Cytochrome P450, in the liver. European Journal of Pharmaceutical Sciences 51, pages 180-188.
Crossref
Crossref
Madoka Nakagomi, Nobuko Fujimaki, Ai Ito, Takahiro Toda, Hiroshi Fukasawa, Koichi Shudo & Ryoichi Tomita. (2013) A Novel Aromatic Carboxylic Acid Inactivates Luciferase by Acylation of an Enzymatically Active Regulatory Lysine Residue. PLoS ONE 8:9, pages e75445.
Crossref
Crossref
Masataka Tajima, Nobutomo Ikarashi, Shintaro Igeta, Takahiro Toda, Makoto Ishii, Yoshikazu Tanaka, Yoshiaki Machida, Wataru Ochiai, Harumi Yamada & Kiyoshi Sugiyama. (2013) Different Diets Cause Alterations in the Enteric Environment and Trigger Changes in the Expression of Hepatic Cytochrome P450 3A, a Drug-Metabolizing Enzyme. Biological and Pharmaceutical Bulletin 36:4, pages 624-634.
Crossref
Crossref
J. Christopher Corton, Pierre R. Bushel, Jennifer Fostel & Raegan B. O’Lone. (2012) Sources of variance in baseline gene expression in the rodent liver. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 746:2, pages 104-112.
Crossref
Crossref
Makoto Ishii, Takahiro Toda, Nobutomo Ikarashi, Wataru Ochiai & Kiyoshi Sugiyama. (2012) Effects of Intestinal Flora on the Expression of Cytochrome P450 3A in the Liver肝臓のチトクロムP450 3Aの発現に及ぼす腸内細菌の影響. YAKUGAKU ZASSHI 132:3, pages 301-310.
Crossref
Crossref
Sandrine P. Claus, Sandrine L. Ellero, Bernard Berger, Lutz Krause, Anne Bruttin, Jérôme Molina, Alain Paris, Elizabeth J. Want, Isabelle de Waziers, Olivier Cloarec, Selena E. Richards, Yulan Wang, Marc-Emmanuel Dumas, Alastair Ross, Serge Rezzi, Sunil Kochhar, Peter Van Bladeren, John C. Lindon, Elaine Holmes & Jeremy K. Nicholson. (2011) Colonization-Induced Host-Gut Microbial Metabolic Interaction. mBio 2:2.
Crossref
Crossref
T A Ajslev, C S Andersen, M Gamborg, T I A Sørensen & T Jess. (2011) Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. International Journal of Obesity 35:4, pages 522-529.
Crossref
Crossref
Erin E. McClelland, André M. Nicola, Rafael Prados-Rosales & Arturo Casadevall. (2010) Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism. Journal of Clinical Investigation 120:4, pages 1355-1361.
Crossref
Crossref
Takahiro Toda, Kanna Ohi, Toshiyuki Kudo, Tomoyuki Yoshida, Nobutomo Ikarashi, Kiyomi Ito & Kiyoshi Sugiyama. (2009) Ciprofloxacin Suppresses Cyp3a in Mouse Liver by Reducing Lithocholic Acid-producing Intestinal Flora. Drug Metabolism and Pharmacokinetics 24:3, pages 201-208.
Crossref
Crossref